Waist Land
Semaglutide goes off patent in India, the plot thickens Aspiration has a new face, and waistline. America’s Ozempic revolution looks to be headed to India, where the semaglutide patent has just expired. It’s the key molecule in GLP-1 weight-loss drugs. One in eight adult Americans is taking such drugs already. If lower costs help make…